Dangerous Drug News: Study: Avandia Increases Heart Failure Risk

According to a study released today by the Journal of American Medical Association (JAMA) the diabetes drug, Avandia, poses a higher risk of heart problems, strokes and deaths that the competing drug, Actos.

The lead author on the study was Dr. David Graham. Graham, who is a scientist for the Food and Drug Administration, has told the Associated Press that up to 100,000 heart attacks, strokes, deaths and cases of heart failure may be attributed to Avandia since it’s debut on the market in 1999.

The JAMA report comes only weeks before the FDA holds an advisory committee meeting, which will offer new reports on Avandia, on July 13th.

More information on the report:

For more information on Avandia, please click here.

About the Author

Hardison & Cochran was established based on the conviction that a modern approach was essential in today’s legal landscape. Focused on delivering exceptional results through a skilled team, the firm prioritizes personal attention, integrity, and client needs. Each attorney, paralegal, and staff member is dedicated to this vision. Over three decades, with Ben Cochran overseeing daily operations, the firm has evolved into a highly respected practice.